- Report
- September 2025
- 411 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Report
- April 2026
- 136 Pages
Global
From €2688EUR$2,999USD£2,306GBP
€3584EUR$3,999USD£3,075GBP
- Report
- June 2026
- 183 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- January 2026
- 180 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- January 2026
- 160 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP
- Report
- August 2026
- 664 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- May 2026
- 150 Pages
United States
From €2500EUR$2,789USD£2,144GBP
- Report
- November 2025
- 180 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- June 2026
- 318 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Report
- December 2025
- 393 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Report
- September 2025
- 379 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Report
- July 2026
- 189 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- July 2026
- 198 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- January 2026
- 195 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- August 2026
- 306 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- June 2026
- 110 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- June 2026
- 180 Pages
Global
From €4257EUR$4,750USD£3,652GBP

The Clinical Microbiology market within the In Vitro Diagnostics (IVD) sector is a rapidly growing field. It is focused on the development and production of diagnostic tests and instruments used to detect and identify microorganisms, such as bacteria, viruses, fungi, and parasites. These tests are used to diagnose and monitor infectious diseases, as well as to detect and monitor antibiotic resistance. Clinical Microbiology tests are used in a variety of settings, including hospitals, laboratories, and point-of-care settings.
The Clinical Microbiology market is driven by the increasing prevalence of infectious diseases, the emergence of new pathogens, and the need for rapid and accurate diagnosis. Additionally, the increasing demand for personalized medicine and the development of new technologies are expected to drive the market in the future.
Some of the major companies in the Clinical Microbiology market include Abbott Laboratories, Becton Dickinson, bioMérieux, Cepheid, Danaher Corporation, Hologic, Qiagen, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more